Subsequent Primary Malignancies Among Myelodysplastic Syndrome Patients Treated with or without Lenalidomide

被引：0
|
作者：
Rollison, Dana E. [1 ]
Shain, Kenneth H. [1 ]
Lee, Ji-Hyun [2 ]
Hampras, Shalaka S. [1 ]
Fisher, Kate [1 ]
Al Ali, Najla H. [1 ]
Padron, Eric [3 ]
Lancet, Jeff E. [1 ]
Olesnyckyj, Marta [4 ]
Kenvin, Laurie [4 ]
Knight, Robert D. [4 ]
Dalton, William [1 ]
List, Alan F. [1 ]
Komrokji, Rami [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA
[3] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[4] Celgene Corp, Summit, NJ USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Subsequent Malignancies in Patients With Li-Fraumeni Syndrome Treated With Radiation Therapy
    Suri, J. S.
    Rednam, S.
    Teh, B. S.
    Butler, E.
    Paulino, A. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S71 - S72
  • [12] Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients
    Rollison, Dana E.
    Shain, Kenneth H.
    Lee, Ji-Hyun
    Hampras, Shalaka S.
    Fulp, William
    Fisher, Kate
    Al Ali, Najla H.
    Padron, Eric
    Lancet, Jeffrey
    Xu, Qiang
    Knight, Robert D.
    List, Alan F.
    Dalton, William
    Komrokji, Rami
    BLOOD, 2014, 124 (21)
  • [13] TELOMERE SHORTENING AND AML PROGRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND DELETION 5Q TREATED WITH LENALIDOMIDE
    Goehring, G.
    Lange, K.
    Hofmann, W.
    Buesche, G.
    Kreipe, H.
    Hellstroem-Lindberg, E.
    Giagounidis, A.
    Schlegelberger, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 378 - 379
  • [14] Lenalidomide effects on NK function in patients with myelodysplastic syndrome (MDS).
    Epling-Burnette, PK
    Bai, FQ
    Painter, JS
    Djeu, JY
    List, AF
    BLOOD, 2005, 106 (11) : 959A - 960A
  • [15] Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy
    Prebet, Thomas
    Toma, Andrea
    Cluzeau, Thomas
    Sekeres, Mikkael A.
    Vey, Norbert
    Park, Sophie
    Al Ali, Najla
    Sugrue, Marie M.
    Komrokji, Rami
    Fenaux, Pierre
    Gore, Steven D.
    ONCOTARGET, 2017, 8 (23) : 37866 - 37874
  • [16] A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide
    Islam, Anwarul
    CLINICAL CASE REPORTS, 2015, 3 (07): : 551 - +
  • [17] Connect MM® - the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide
    Rifkin, Robert M.
    Abonour, Rafat
    Shah, Jatin J.
    Mehta, Jayesh
    Narang, Mohit
    Terebelo, Howard
    Gasparetto, Cristina
    Toomey, Kathleen
    Hardin, James W.
    Lu, Jane Jie
    Kenvin, Laurie
    Srinivasan, Shankar
    Knight, Robert
    Nagarwala, Yasir
    Durie, Brian G. M.
    LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2228 - 2231
  • [18] Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis
    Saleem, Kainat
    Franz, Joseph
    Klem, Mary Lou
    Yabes, Jonathan G.
    Boyiadzis, Michael
    Jones, John R.
    Shaikh, Nader
    Lontos, Konstantinos
    LANCET HAEMATOLOGY, 2022, 9 (12): : E906 - E918
  • [19] Outcome of Patients Treated for Myelodysplastic Syndromes after Failure of Lenalidomide Therapy
    Prebet, Thomas
    Cluzeau, Thomas
    Park, Sophie
    Germing, Ulrich
    Ades, Lionel
    Platzbecker, Uwe
    Vey, Norbert
    Goetze, Katharina
    Kelaidi, Charikleia
    Oliva, Esther Natalie
    Al Ali, Najla H.
    Fenaux, Pierre
    Gore, Steven D.
    Komrokji, Rami S.
    BLOOD, 2015, 126 (23)
  • [20] Distinct mutational pattern of myelodysplastic syndromes with and without 5q-treated with lenalidomide
    Adema, Vera
    Palomo, Laura
    Toma, Andrea
    Kosmider, Olivier
    Fuster-Tormo, Francisco
    Benito, Rocio
    Salgado, Rocio
    Such, Esperanza
    Larrayoz, Maria Jose
    Xicoy, Blanca
    Hernandez-Sanchez, Jesus Maria
    Maietta, Paolo
    Neef, Alexander
    Fontenay, Michaela
    Ibanez, Mariam
    Diez-Campelo, Maria
    Alvarez, Sara
    Maciejewski, Jaroslaw P.
    Fenaux, Pierre
    Sole, Francesc
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) : E131 - E135
12345